Bio-Rad Laboratories (BIO-B) Long-Term Deferred Tax (2009 - 2019)

Bio-Rad Laboratories (BIO-B) has 11 years of Long-Term Deferred Tax data on file, last reported at $138.0 million in Q4 2019.

• Quarterly Long-Term Deferred Tax rose 80.87% year-over-year to $138.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $138.0 million (up 80.87% YoY) and the FY2019 annual result came in at $138.0 million, up 80.87% from the prior year.
• Long-Term Deferred Tax advanced to $138.0 million in Q4 2019 per BIO-B's latest filing, from $76.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $138.0 million in Q4 2019 and bottomed at $76.3 million in Q4 2018.
• The 5-year median for Long-Term Deferred Tax is $99.5 million (2015), against an average of $102.2 million.
• The widest annual swing landed in 2017, when Long-Term Deferred Tax slumped 32.77%; it then soared 80.87% in 2019.
• Tracing BIO-B's Long-Term Deferred Tax over 5 years: stood at $99.5 million in 2015, then advanced by 18.39% to $117.8 million in 2016, then tumbled by 32.77% to $79.2 million in 2017, then fell by 3.66% to $76.3 million in 2018, then jumped by 80.87% to $138.0 million in 2019.
• Per Business Quant, the three latest BIO-B Long-Term Deferred Tax figures stand at $138.0 million (Q4 2019), $76.3 million (Q4 2018), and $79.2 million (Q4 2017).

Peer Comparison